Another limitation was the absence of direct comparisons with other biomarkers such as ELF, Fibrospect, Fibrometer and Fibroscan for fibrosis, cytokeratin 18 for NASH, and magnetic resonance imaging and spectroscopy for steatosis [7], [8], [30]. The gene discussed is KRT18; the disease is metabolic dysfunction-associated steatohepatitis.